Connecticut Innovations said Thursday that it expects to earn three times its initial investment in Wallingford’s CyVek, which last week agreed to be acquired by a Minnesota company for as much as $195 million.
CI invested nearly $2 million in the company, which makes biochemical tests, and expects to receive approximately $6 million, once the deal is final.
David Wurzer, CI’s chief investment officer, said in a statement that the organization will use the proceeds to invest in other innovative companies in the state.
